BCG Tuberculosis (TB) Vaccine Market Report

Europe BCG Tuberculosis (TB) Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 28, 2020
  • PAGES：183
  • REPORT CODE：GMM523810
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The BCG Tuberculosis (TB) Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe BCG Tuberculosis (TB) Vaccine Market Segmentations:

    By Player:

    • China National Biotec

    • Japan BCG Lab

    • Merck

    • GSBPL

    • Sanofi Pasteur

    • Serum Institute of India

    • Intervax

    By Type:

    • Immune BCG

    • Therapy BCG

    By End-User:

    • Hospital

    • Clinic

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of BCG Tuberculosis (TB) Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Immune BCG from 2014 to 2026

    • 1.3.2 Europe BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Therapy BCG from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Europe BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of BCG Tuberculosis (TB) Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of BCG Tuberculosis (TB) Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Immune BCG

      • 3.4.2 Market Size and Growth Rate of Therapy BCG

    4 Segmentation of BCG Tuberculosis (TB) Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of BCG Tuberculosis (TB) Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of BCG Tuberculosis (TB) Vaccine for Hospital

      • 4.4.2 Market Size and Growth Rate of BCG Tuberculosis (TB) Vaccine for Clinic

    5 Market Analysis by Major Regions

    • 5.1 Europe BCG Tuberculosis (TB) Vaccine Production Analysis by Top Regions

    • 5.2 Europe BCG Tuberculosis (TB) Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of BCG Tuberculosis (TB) Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in BCG Tuberculosis (TB) Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in BCG Tuberculosis (TB) Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in BCG Tuberculosis (TB) Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in BCG Tuberculosis (TB) Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in BCG Tuberculosis (TB) Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in BCG Tuberculosis (TB) Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 7.1 Germany BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 7.2 Germany BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    8. UK BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 8.1 UK BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 8.2 UK BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    9. France BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 9.1 France BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 9.2 France BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    10. Italy BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 10.1 Italy BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 10.2 Italy BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    11. Spain BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 11.1 Spain BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 11.2 Spain BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    12. Poland BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 12.1 Poland BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 12.2 Poland BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    13. Russia BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 13.1 Russia BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 13.2 Russia BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    14. Switzerland BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 14.1 Switzerland BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    15. Turkey BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 15.1 Turkey BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 China National Biotec

      • 19.1.1 China National Biotec Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Japan BCG Lab

      • 19.2.1 Japan BCG Lab Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Merck

      • 19.3.1 Merck Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 GSBPL

      • 19.4.1 GSBPL Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Sanofi Pasteur

      • 19.5.1 Sanofi Pasteur Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Serum Institute of India

      • 19.6.1 Serum Institute of India Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Intervax

      • 19.7.1 Intervax Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    The List of Tables and Figures (Totals 98 Figures and 157 Tables)

    • Figure Product Picture

    • Figure Europe BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Immune BCG from 2014 to 2026

    • Figure Europe BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Therapy BCG from 2014 to 2026

    • Figure Europe BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Europe BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Germany BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania BCG Tuberculosis (TB) Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of BCG Tuberculosis (TB) Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of BCG Tuberculosis (TB) Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of BCG Tuberculosis (TB) Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of BCG Tuberculosis (TB) Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Immune BCG

    • Figure Market Size and Growth Rate of Therapy BCG

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of BCG Tuberculosis (TB) Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of BCG Tuberculosis (TB) Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Table Europe BCG Tuberculosis (TB) Vaccine Production by Major Regions

    • Table Europe BCG Tuberculosis (TB) Vaccine Production Share by Major Regions

    • Figure Europe BCG Tuberculosis (TB) Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe BCG Tuberculosis (TB) Vaccine Consumption by Major Regions

    • Table Europe BCG Tuberculosis (TB) Vaccine Consumption Share by Major Regions

    • Table Germany BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table UK BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table France BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in BCG Tuberculosis (TB) Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in BCG Tuberculosis (TB) Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in BCG Tuberculosis (TB) Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in BCG Tuberculosis (TB) Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table Germany BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table UK BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table France BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table France BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table France BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table Italy BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table Spain BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table Poland BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table Russia BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) BCG Tuberculosis (TB) Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) BCG Tuberculosis (TB) Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) BCG Tuberculosis (TB) Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries BCG Tuberculosis (TB) Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of China National Biotec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China National Biotec

    • Figure Sales and Growth Rate Analysis of China National Biotec

    • Figure Revenue and Market Share Analysis of China National Biotec

    • Table Product and Service Introduction of China National Biotec

    • Table Company Profile and Development Status of Japan BCG Lab

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Japan BCG Lab

    • Figure Sales and Growth Rate Analysis of Japan BCG Lab

    • Figure Revenue and Market Share Analysis of Japan BCG Lab

    • Table Product and Service Introduction of Japan BCG Lab

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of GSBPL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSBPL

    • Figure Sales and Growth Rate Analysis of GSBPL

    • Figure Revenue and Market Share Analysis of GSBPL

    • Table Product and Service Introduction of GSBPL

    • Table Company Profile and Development Status of Sanofi Pasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur

    • Figure Sales and Growth Rate Analysis of Sanofi Pasteur

    • Figure Revenue and Market Share Analysis of Sanofi Pasteur

    • Table Product and Service Introduction of Sanofi Pasteur

    • Table Company Profile and Development Status of Serum Institute of India

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India

    • Figure Sales and Growth Rate Analysis of Serum Institute of India

    • Figure Revenue and Market Share Analysis of Serum Institute of India

    • Table Product and Service Introduction of Serum Institute of India

    • Table Company Profile and Development Status of Intervax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intervax

    • Figure Sales and Growth Rate Analysis of Intervax

    • Figure Revenue and Market Share Analysis of Intervax

    • Table Product and Service Introduction of Intervax

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US